Bio-Path Holdings, Inc. (BPTH) stock is experiencing a significant surge today, driven by the company’s announcement of a therapeutic program for treating obesity and related metabolic diseases using its DNAbilize technology. Additionally, the company provided positive updates on its ongoing clinical trials for both leukemia and solid tumor treatments.